This medication is taken by injection.
Rebif® is a medication manufactured by a biotechnological process from one of the naturally-occurring interferons (a type of protein). It is made up of exactly the same amino acids (major components of proteins) as the interferon beta found in the human body.
Rebif is approved for the treatment of relapsing forms of multiple sclerosis, which include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease (SPMS with relapses).
Click here to read the Rebif prescribing information for healthcare professionals.
Click here to read the Rebif Medication Guide for patients.
REBIF SUPPORT PROGRAM
Financial Assistance Program